This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on Web of Science (11)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

JOHN T. CRISSEY, M.D.; PHILIP F. MURRAY, M.D.

AMA Arch Derm. 1956;74(1):69-72.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

With the report of Page in 1951¹ on the use of quinacrine in the treatment of chronic discoid lupus erythematosus and the subsequent reports of Goldman and others² and Pillsbury and Jacobson³ in 1953 and 1954 on the successful use of the less toxic and more esthetically acceptable chloroquine, it has become clear that the therapy of this disease needs reevaluation. Since no dependable data are available on the natural course of lupus erythematosus, the logical approach to the evaluation of new drugs is a careful comparison of results obtained with them and results accumulated in the use of older, standard medications. The purpose of this paper is to compare chloroquine with gold sodium thiosulfate in the treatment of chronic discoid lupus erythematosus.

Five points of comparison were considered note-worthy:

1. Number of successes and failures
   
2. Rates at which clinical remission took place
   

Author Affiliations
Buffalo

From the Laboratory for Dermatologic Research, E. J. Meyer Memorial Hospital, Dr. Earl D. Osborne, Director.

Footnotes
Submitted for publication Aug. 18, 1955.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?